논문KCI 등재
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
참고문헌 (3)
- Yi-Wen Ting, "Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort", Clinical and Molecular Hepatology, 27(3), pp.486~498 (2021), 대한간학회[DOI]
- Gellert-Kristensen H, "Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population", Hepatology, 72, pp.845~856 (2020)
- Koo BK, "Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 18, pp.2592~2599 (2020)
관련 논문AI추천
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune responseCarlos J. Pirola, Silvia Sookoian대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Personalized medicine in nonalcoholic fatty liver diseaseCarlos J. Pirola, Silvia Sookoian대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver DiseaseGeorge Boon-Bee Goh, Yiying Pei거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제1호Implications of comorbidities in nonalcoholic fatty liver diseaseSherlot Juan Song, Vincent Wai-Sun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspectiveCarlos Jose Pirola, Silvia Sookoian대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease김원, Seonghwan Hwang대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호
이 간행물의 다른 논문 (13건)
KASL clinical practice guidelines: Management of nonalcoholic fatty liver diseaseDo Seon Song, 이혜원, 조유리, 정수진, 고홍, 김승업, Won Kim, Jeong-Ju Yoo, Tae Hee Lee, 최준일, Sang Bong Ahn, Soung Won Jeong, Sang Gyune Kim, Haeryoung Kim, Dae Won Jun, Byoung Kuk Jang, Yong Kyun Cho, The Korean Association for the Study of the Liver (KASL), 김문영, 강성희, Jin Woo Leepp. 363-401Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma김승업, Sung Won Lee, Jonggi Choi, Young-Suk Limpp. 402-412Anti-fibrotic treatments for chronic liver diseases: The present and the futureNaoshi Odagiri, Norifumi Kawada, Misako Sato-Matsubara, Tsutomu Matsubara, Masaru Enomoto, Hideki Fujiipp. 413-424β-blockers in advanced cirrhosis: More friend than enemySamuel S. Lee, Ki Tae Yoon, Hongqun Liupp. 425-436Changes in the epidemiology and management of bacterial infections in cirrhosisMarta Tonon, Salvatore Piano, Paolo Angelipp. 437-445